GID.AX - GI Dynamics, Inc.

ASX - ASX Delayed Price. Currency in AUD

GI Dynamics, Inc.

355 Congress Street
4th Floor
Boston, MA 02210
United States

IndustryMedical Devices
Full-time employees13

Key executives

NameTitlePayExercisedYear born
Mr. Scott W. SchorerCEO & Pres400kN/A1968
Mr. Charles CarterCFO, Treasurer & Sec.N/AN/AN/A
Keith Gersin M.D., F.A.C.S.Chief Medical AdvisorN/AN/AN/A
Houry YoussoufianVP of Fin. & AccountingN/AN/AN/A
Dr. Manoel Galvao Neto M.D.Scientific Advisor of Gastroenterology & Member of Scientific Advisory BoardN/AN/AN/A
Amounts are as of 31 December 2017, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


GI Dynamics, Inc., a medical device company, engages in the design and application of devices and disease management solutions for treatment of metabolic diseases. The company offers EndoBarrier, a medical device for the treatment of patients with type 2 diabetes and obesity. It serves health care providers, such as hospitals and physicians; and third-party distributors. The company sells its products primarily in Europe, the Middle East, the Asia Pacific, and South America. GI Dynamics, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.

Corporate governance

GI Dynamics, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.